Welcome to our dedicated page for OneMedNet news (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet stock.
OneMedNet Corp provides healthcare data and software solutions focused on regulatory-grade, AI-ready real-world data for life sciences, medical device, research, and AI customers. Company news commonly centers on the OneMedNet iRWD™ platform, its Palantir Foundry-powered search and data access capabilities, and the commercialization of subscription-based real-world data products.
Recurring developments include platform launches, bookings and revenue updates, data licensing agreements, and collaborations that expand disease-specific and multimodal datasets. Recent company updates have discussed oncology, autoimmune, neurotechnology, medical imaging, electronic health records, longitudinal patient data, cohort discovery, and real-world evidence generation.
OneMedNet (Nasdaq: ONMD) announced that its regulatory-grade Real-World Data supported mlHealth 360 in obtaining FDA 510(k) clearance for Scaida BrainCT-ICH, an AI software to detect intracranial hemorrhage from head CT scans. OneMedNet supplied multimodal datasets spanning longitudinal EMR, diagnostic imaging, and clinical reports to support model development, validation, and the regulatory submission. Scaida BrainCT-ICH identifies suspected ICH in approximately 5.97 seconds after image acquisition, which the companies say enables faster clinical triage.
This milestone is presented as validation of OneMedNet’s data quality and its role as a trusted partner for regulated AI and life‑sciences submissions.
OneMedNet (Nasdaq: ONMD) delivered an anonymized Real-World Data feed covering 1.5 million patients and 4 million encounters to a healthcare data and analytics organization on January 2026. The multimodal dataset exceeds 1.49 billion datapoints and includes longitudinal clinical domains such as practitioner notes, immunizations, conditions, medications, encounters, and observations. Delivered under OneMedNet’s subscription model and powered by Palantir AIP Foundry, the feed supported enterprise-scale testing, validation, and demonstrated ingestion, harmonization, and operationalization of complex healthcare data, positioning the company to scale subscription-based RWD delivery and pursue additional customers.
OneMedNet (Nasdaq: ONMD) CEO Aaron Green reviewed 2025 progress and outlined plans for 2026. Key achievements include a $19.6 million reduction in total liabilities (~75% lower versus Dec 31, 2024), selection and integration of Palantir's AI platform to accelerate an AI-driven multimodal subscription search planned for launch in early 2026, and a 37% YOY network expansion reaching 186 million clinical exams across >2,130 provider sites.
Other highlights: third-quarter bookings rose eightfold YOY, growth of commercial and operations teams, and a 2026 roadmap to add HEOR and analytics services while pursuing recurring subscription revenue from large-scale RWD access.
OneMedNet (Nasdaq: ONMD) reported strong engagement and growing commercial traction at the Radiological Society of North America (RSNA) Annual Meeting on Dec 10, 2025. The company said hospitals, imaging centers, and life sciences firms showed interest in joining its provider network and using the updated iRWD™ platform powered by Palantir Foundry. Attendees cited rapid deployment, regulatory-grade data quality, multimodal longitudinal coverage, and AI-enabled cohort discovery that shortens feasibility from weeks to minutes.
OneMedNet emphasized continued network growth, expanded multimodal assets, and a focus on delivering scalable regulatory-grade real-world data to accelerate evidence generation and product development.
OneMedNet (Nasdaq: ONMD) will showcase a redesigned data exploration and cohort-building platform at RSNA 2025 after receiving strong validation from customers and prospects at ISPOR Europe on Nov 24, 2025.
The platform, rebuilt on Palantir Foundry and AIP, connects to OneMedNet’s iRWD network covering 2,130+ provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images. Key advances include faster cohort feasibility (minutes vs weeks), AI-driven natural-language search, real-time longitudinal insights, and subscription workflow integration to support recurring revenue.
Attendees are invited to Booth #1742, South Hall, for live demonstrations.
OneMedNet (Nasdaq: ONMD) announced a major iRWD network expansion on November 20, 2025 that it says strengthens its subscription offerings and position as a leading regulatory-grade Real-World Data network.
Key metrics in the three months since August 2025: provider sites added ~380 to a total exceeding 2,130 (+22%); unique de-identified patient records increased by 13 million to > 47 million (+38%); clinical exams and images grew by 50 million to > 186 million (+37%).
The company said these expansions are accelerating its subscription model and recurring revenue as pharma, life-science, and AI customers seek ongoing access to longitudinal cohorts in the estimated $60 billion Real-World Evidence market.
OneMedNet (Nasdaq:ONMD) reported third-quarter results for the period ended Sept 30, 2025, highlighting material operational and financial moves.
Key figures: Q3 bookings of $1.1M (an 815% increase year-over-year); an additional $0.5M insider private placement; reduction of total liabilities by $1.9M in Q3 and $14.3M year-to-date; and a reported 4.5x increase in inbound demand.
Operational updates: a September 2025 pilot integrating Palantir's AI Platform with OneMedNet's iRWD network and a rollout of a Palantir-powered SaaS subscription model offering live data feeds and AI-driven conversational search to build recurring revenue.
OneMedNet (Nasdaq: ONMD) announced its next‑generation iRWD™ subscription platform, built on Palantir Foundry and AIP, and will demonstrate it at ISPOR Europe on Nov 10, 2025. The subscription model offers two products: Live Data Feeds for continuous de‑identified clinical data streams and AI‑Driven Conversational Search for natural‑language cohort building.
The company says the offerings convert static data access into dynamic, regulatory‑grade, multimodal RWD for real‑time insights and recurring revenue. The release cites an estimated US$868 billion AI‑healthcare market opportunity by 2030.
OneMedNet (Nasdaq:ONMD) announced on October 20, 2025 that mlHealth360 has signed a multi-year subscription to OneMedNet’s iRWD™ platform for regulatory-grade, de-identified imaging and clinical data.
The subscription gives mlHealth360 ongoing access to curated X-ray and CT datasets sourced from 1,750+ healthcare provider sites and 131 million+ clinical studies, supporting AI model development, validation, and deployment. OneMedNet said the deal advances its subscription-based strategy and helps scale annual recurring revenue by expanding its customer base of AI and analytics firms.
Palantir Technologies (NASDAQ: PLTR) signed a multi-year agreement to provide its Artificial Intelligence Platform to OneMedNet’s iRWD™ near real-time AI provider network. The integration will combine Palantir analytics with OneMedNet access to 5 billion administrative claims, 131 million clinical exams and > 1,750 provider sites, spanning oncology, cardiology, and rare diseases. The platform aims to enable faster data discovery (minutes vs days), custom cohort creation, conversational AI search, automated workflows, and large-scale de-identification to deliver regulatory-grade, anonymized clinical data to life sciences and medical device customers. OneMedNet positions the partnership to pursue scalable recurring revenue and accelerate clinical research and AI-driven healthcare solutions.